IFNG and melanoma: IFN-γ, but not IFN-α, treatment (Figure S2A) significantly upregulated HLA class II surface expression in 5/11 HLA class II-negative melanoma cells, but to a distinct extend regarding its kinetics and intensity (Figure 2a).